These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16498401)

  • 1. In vivo role of the HNF4alpha AF-1 activation domain revealed by exon swapping.
    Briançon N; Weiss MC
    EMBO J; 2006 Mar; 25(6):1253-62. PubMed ID: 16498401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of glucocorticoid receptor and hepatocyte nuclear factor 4alpha (HNF4alpha) binding to the hnf4alpha gene in the liver.
    Bailly A; Briançon N; Weiss MC
    Biochimie; 2009 Sep; 91(9):1095-103. PubMed ID: 19540905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of constitutive androstane receptor expression by hepatocyte nuclear factor4alpha isoforms.
    Pascussi JM; Robert A; Moreau A; Ramos J; Bioulac-Sage P; Navarro F; Blanc P; Assenat E; Maurel P; Vilarem MJ
    Hepatology; 2007 May; 45(5):1146-53. PubMed ID: 17464991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte nuclear factor 4 alpha ligand binding and F domains mediate interaction and transcriptional synergy with the pancreatic islet LIM HD transcription factor Isl1.
    Eeckhoute J; Briche I; Kurowska M; Formstecher P; Laine B
    J Mol Biol; 2006 Dec; 364(4):567-81. PubMed ID: 17022998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HNF4alpha isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3' end splicing.
    Torres-Padilla ME; Fougère-Deschatrette C; Weiss MC
    Mech Dev; 2001 Dec; 109(2):183-93. PubMed ID: 11731232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hepatocyte nuclear factor 4alpha in developing mice.
    Kanazawa T; Konno A; Hashimoto Y; Kon Y
    Anat Histol Embryol; 2009 Feb; 38(1):34-41. PubMed ID: 18803630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of hepatic nuclear factor 4alpha on expression of human hepatic stimulator substance via its action on the proximal promoter in HepG2 cells.
    Guo D; Dong LY; Wu Y; Yang L; An W
    Biochem J; 2008 Oct; 415(1):111-21. PubMed ID: 18513187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alternative splice variant of the tissue specific transcription factor HNF4alpha predominates in undifferentiated murine cell types.
    Nakhei H; Lingott A; Lemm I; Ryffel GU
    Nucleic Acids Res; 1998 Jan; 26(2):497-504. PubMed ID: 9421506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal and nutritional regulation of alternative CD36 transcripts in rat liver--a role for growth hormone in alternative exon usage.
    Cheung L; Andersen M; Gustavsson C; Odeberg J; Fernández-Pérez L; Norstedt G; Tollet-Egnell P
    BMC Mol Biol; 2007 Jul; 8():60. PubMed ID: 17640331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
    Tanaka T; Jiang S; Hotta H; Takano K; Iwanari H; Sumi K; Daigo K; Ohashi R; Sugai M; Ikegame C; Umezu H; Hirayama Y; Midorikawa Y; Hippo Y; Watanabe A; Uchiyama Y; Hasegawa G; Reid P; Aburatani H; Hamakubo T; Sakai J; Naito M; Kodama T
    J Pathol; 2006 Apr; 208(5):662-72. PubMed ID: 16400631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new transcript splice variant of the human glucocorticoid receptor: identification and tissue distribution of hGR Delta 313-338, an alternative exon 2 transactivation domain isoform.
    Turner JD; Schote AB; Keipes M; Muller CP
    Ann N Y Acad Sci; 2007 Jan; 1095():334-41. PubMed ID: 17404046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple promoters regulate tissue-specific alternative splicing of the human kallikrein gene, KLK11/hippostasin.
    Mitsui S; Nakamura T; Okui A; Kominami K; Uemura H; Yamaguchi N
    FEBS J; 2006 Aug; 273(16):3678-86. PubMed ID: 16911518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific transcription factor HNF4alpha inhibits cell proliferation and induces apoptosis in the pancreatic INS-1 beta-cell line.
    Erdmann S; Senkel S; Arndt T; Lucas B; Lausen J; Klein-Hitpass L; Ryffel GU; Thomas H
    Biol Chem; 2007 Jan; 388(1):91-106. PubMed ID: 17214554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of HNF4alpha isoforms in liver stem cells and hepatocytes.
    Li K; Zhang H; Wang Y; Wang Y; Feng M
    J Cell Biochem; 2006 Oct; 99(2):558-64. PubMed ID: 16639723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of interactions of hepatocyte nuclear factor 4alpha isoforms with coactivators and corepressors are promoter-specific.
    Torres-Padilla ME; Weiss MC
    FEBS Lett; 2003 Mar; 539(1-3):19-23. PubMed ID: 12650919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte nuclear factor 4 alpha is related to survival of the condensed mesenchyme in the developing mouse kidney.
    Kanazawa T; Konno A; Hashimoto Y; Kon Y
    Dev Dyn; 2010 Apr; 239(4):1145-54. PubMed ID: 20235219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HNF4alpha variants in pancreatic islets and Ins-1 beta cells.
    Huang J; Karakucuk V; Levitsky LL; Rhoads DB
    Diabetes Metab Res Rev; 2008 Oct; 24(7):533-43. PubMed ID: 18561282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative promoter usage and alternative splicing contribute to mRNA heterogeneity of mouse monocarboxylate transporter 2.
    Zhang SX; Searcy TR; Wu Y; Gozal D; Wang Y
    Physiol Genomics; 2007 Dec; 32(1):95-104. PubMed ID: 17911380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing variations in mouse CAPS2: differential expression and functional properties of splicing variants.
    Sadakata T; Washida M; Furuichi T
    BMC Neurosci; 2007 Apr; 8():25. PubMed ID: 17428348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
    Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
    Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.